Back to Rankings

OMER

OmerosD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
OMER vs peer average
38/100
OMER vs. peer average (D vs. C)
Grade spread
B 3 · C 4 · D 2 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

PCRX is the first available peer comparator.

Closest commercial-execution comp in the packet: a similarly sized biopharma where adoption, contracting and product concentration matter more than broad platform optionality.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerPCRXPacira Biosciences
OMER
Omeros
PCRX
Pacira Biosciences
Grade
D
B
Momentum
10
43
Value
41
69
Sentiment
64
48
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs PCRX

OMER / PCRX
Grade Position
Below peers
OMER vs. peer average (D vs. C)
38/100
Momentum
10
PCRX
Value
41
PCRX
Sentiment
64
OMER

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs OMER
1
PCRX
PCRX
B
80/100
-2
2
NTLA
NTLA
C
60/100
-1
3
REGN
REGN
C
60/100
-1
4
OCS
Oculis Holding AG Common
F
20/100
+1
5
EVO
Evotec SE ADR
B
80/100
-2
PCRX is the first peer returned for this comparison set.